The Human Papillomavirus Oncoprotein E7 Attenuates NF-κB Activation by Targeting the IκB Kinase Complex*

Infection with high-risk human papillomaviruses (HPV) can lead to the development of cervical carcinomas. This process critically depends on the virus-encoded E6 and E7 oncoproteins, which stimulate proliferation by manipulating the function of a variety of host key regulatory proteins. Here we show that both viral proteins dose-dependently interfere with the transcriptional activity of NF-κB. A variety of experimental approaches revealed that a fraction of the E7 proteins is found in association with the IκB kinase complex and attenuates induced kinase activity of IκB kinase α (IKKα) and IKKβ, thus resulting in impaired IκBα phosphorylation and degradation. Indirect immunofluorescence shows that E7 impairs TNFα-induced nuclear translocation of NF-κB, thus preventing NF-κB from binding to its cognate DNA. While E7 obviates IKK activation in the cytoplasm, the E6 protein reduces NF-κB p65-dependent transcriptional activity within the nucleus. We suggest that HPV oncogene-mediated suppression of NF-κB activity contributes to HPV escape from the immune system.

[1]  F. Vikhanskaya,et al.  Human papillomavirus type 16 E6‐enhanced susceptibility to apoptosis induced by TNF in A2780 human ovarian cancer cell line , 2002, International journal of cancer.

[2]  R. Wu,et al.  Increased p50/p50 NF-κB Activation in Human Papillomavirus Type 6- or Type 11-Induced Laryngeal Papilloma Tissue , 2002, Journal of Virology.

[3]  R. Tindle Immune evasion in human papillomavirus-associated cervical cancer , 2002, Nature Reviews Cancer.

[4]  T. Maniatis,et al.  NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .

[5]  A. Sampath,et al.  Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells , 2001, Oncogene.

[6]  C. Woodworth,et al.  Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-κB-Responsive Genes in Cervical Keratinocytes , 2001, Journal of Virology.

[7]  J. Nevins,et al.  The Rb/E2F pathway and cancer. , 2001, Human molecular genetics.

[8]  Chris Albanese,et al.  NF-κB and cell-cycle regulation: the cyclin connection , 2001 .

[9]  J. Mazzarelli,et al.  Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein. , 2000, Biochemistry.

[10]  G. Blair,et al.  Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins , 2000, Oncogene.

[11]  P. Cohen,et al.  Human Papillomavirus Type 16 E7 Oncoprotein Binds and Inactivates Growth-Inhibitory Insulin-Like Growth Factor Binding Protein 3 , 2000, Molecular and Cellular Biology.

[12]  W. Chien,et al.  Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  J. de Graaf,et al.  A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. , 2000, Virology.

[14]  Ajay Mahaputra Kumar,et al.  PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein* , 2000, The Journal of Biological Chemistry.

[15]  F. Dick,et al.  Mutagenesis of the pRB Pocket Reveals that Cell Cycle Arrest Functions Are Separable from Binding to Viral Oncoproteins , 2000, Molecular and Cellular Biology.

[16]  Harald zur Hausen,et al.  Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis , 2000 .

[17]  K. Vousden,et al.  Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.

[18]  A. Israël The IKK complex: an integrator of all signals that activate NF-κB? , 2000 .

[19]  T. Hofmann,et al.  Mixed-Lineage Kinase 3 Delivers CD3/CD28-Derived Signals into the IκB Kinase Complex , 2000, Molecular and Cellular Biology.

[20]  W. Nickel,et al.  Allosteric Activation of Acid α-Glucosidase by the Human Papillomavirus E7 Protein* , 2000, The Journal of Biological Chemistry.

[21]  Jong-Sup Park,et al.  Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein , 2000, The Journal of Biological Chemistry.

[22]  S. Caldeira,et al.  Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein , 2000, Oncogene.

[23]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[24]  H. Hausen Viruses in human cancers , 1991 .

[25]  M. Karin,et al.  JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.

[26]  M. Henriksson,et al.  Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation , 1999, Oncogene.

[27]  K. Smith-McCune,et al.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Banks,et al.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Ghosh Regulation of inducible gene expression by the transcription factor NF-κB , 1999 .

[30]  Miranda Thomas,et al.  Inhibition of Bak-induced apoptosis by HPV-18 E6 , 1998, Oncogene.

[31]  M. Karin,et al.  JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? , 1998 .

[32]  M. Vidal,et al.  Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. , 1998, Genes & development.

[33]  W. Fiers,et al.  Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Pim,et al.  Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity. , 1997, The Journal of general virology.

[35]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[36]  M. von Knebel Doeberitz,et al.  p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. , 1996, Oncogene.

[37]  M. Schmitz,et al.  The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K , 1996, Molecular and cellular biology.

[38]  M. Birrer,et al.  The human papillomavirus type 16 E7 gene product interacts with and trans‐activates the AP1 family of transcription factors. , 1996, The EMBO journal.

[39]  L. Laimins,et al.  Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. , 1996, Virology.

[40]  E. Tartour,et al.  Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. , 1994, Cancer research.

[41]  M. von Knebel Doeberitz,et al.  Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions , 1994, Journal of virology.

[42]  M. Yutsudo,et al.  Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. , 1994, Virology.

[43]  T. Luger,et al.  Increased tumorigenicity of human keratinocytes harboring human papillomavirus type 16 is associated with resistance to endogenous tumor necrosis factor‐α‐mediated growth limitation , 1994, International journal of cancer.

[44]  N. Hachiya,et al.  Functional oligomerization of purified human papillomavirus types 16 and 6b E7 proteins expressed in Escherichia coli. , 1994, The Journal of general virology.

[45]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[46]  T. Gilmore Role of rel family genes in normal and malignant lymphoid cell growth. , 1992, Cancer surveys.

[47]  P. Baeuerle,et al.  The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B. , 1991, The EMBO journal.

[48]  S. Nagata,et al.  pEF-BOS, a powerful mammalian expression vector. , 1990, Nucleic acids research.

[49]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[50]  D. Lowy,et al.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.

[51]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[52]  T. Crook,et al.  Continued expression of HPV‐16 E7 protein is required for maintenance of the transformed phenotype of cells co‐transformed by HPV‐16 plus EJ‐ras. , 1989, The EMBO journal.